Bridging Innovation and Impact: Why Evidence Generation is the New Currency in Biotech

Discover how biotech companies strategically leverage medical evidence generation to demonstrate value, accelerate market access, and drive real-world impact.

Peter M. Neupert

Peter Neupert serves as Fortrea’s Chairman and Interim Chief Executive Officer.

Sustainability in Clinical Trials

Dana Annunziato

Dana has more than 25 years of experience in the pharmaceutical and CRO industry, with 9 years at Fortrea.

How assumptions in protocol design are a root of trial failure: Avoiding “unicorns” in clinical trial protocol design

Accelerate your success with Fortrea’s Site Support Services

NICE technology appraisals of oncology treatments

Clare Campbell-Cooper

Clare Campbell-Cooper joined Fortrea in February 2020 and serves as its Global Head of Digital Health and Innovation. Clare has over 25 years of industry experience and is a recognized leader within the field of digital health.

Kiki Zhang

Kiki Zhang, is the Senior Director of Digital Strategy at Fortrea, based in Shanghai, China.